Meng Yuanbiao, Zou Quanqing, Liu Tianqi, Cai Xiaoyong, Huang Yubin, Pan Jinfei
Department of General Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Department of Hepatobiliary and Endocrine Surgery, The People's Hospital ofGuangxi Zhuang Autonomous Region, Nanning, Guangxi 530021, P.R. China.
Mol Med Rep. 2021 Sep;24(3). doi: 10.3892/mmr.2021.12278. Epub 2021 Jul 19.
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the cell cycle assay data shown in Fig. 4A, and the western blotting assay data shown in Fig. 4B, were strikingly similar to data appearing in different form in other articles by different authors; furthermore, there were other possible anomalies associated with these data. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive any reply. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in 11: 379‑385, 2015; DOI: 10.3892/mmr.2014.2684].
在本文发表后,一位关注此事的读者提醒编辑注意,图4A所示的细胞周期分析数据以及图4B所示的蛋白质印迹分析数据与不同作者在其他文章中以不同形式呈现的数据惊人地相似;此外,这些数据还存在其他可能的异常情况。由于上述文章中存在争议的数据在提交给[杂志名称]之前已在其他地方发表,或已在考虑发表,编辑决定将本文从该杂志撤回。已要求作者对这些问题作出解释,但编辑部未收到任何回复。编辑就由此造成的不便向读者表示歉意。[原文发表于《分子医学报道》2015年第11卷第379 - 385页;DOI: 10.3892/mmr.2014.2684]